Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
about
Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trialMolecular targets for flavivirus drug discoveryGuiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccineAdvanced vaccine candidates for Lassa feverThe yellow fever 17D virus as a platform for new live attenuated vaccinesEarly IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responsesEnvelope exchange for the generation of live-attenuated arenavirus vaccinesA recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host CellsConstruction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genesE Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate VirulenceViral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virusComprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice modelClosing the door on flaviviruses: Entry as a target for antiviral drug designA Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus InfectionDynamics of the CD8 T-cell response following yellow fever virus 17D immunizationImmune activation alters cellular and humoral responses to yellow fever 17D vaccineCharacterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T CellsSingle-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcomeAdaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccinationSystems biology approach predicts immunogenicity of the yellow fever vaccine in humansPathogenesis and Inhibition of Flaviviruses from a Carbohydrate PerspectiveT Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal ModelsHerpes Simplex Virus and Interferon Signaling Induce Novel Autophagic Clusters in Sensory NeuronsImmune gene networks of mycobacterial vaccine-elicited cellular responses and immunity.Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoeliiYellow fever: a reemerging threatYellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunityJapanese encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cellsBiological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genomeCD8+ T cells complement antibodies in protecting against yellow fever virus.Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.Designing the optimal vaccine: the importance of cytokines and dendritic cells.Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination.CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses.Yellow Fever 17DD Vaccine Virus Infection Causes Detectable Changes in Chicken Embryos.Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.The Roles and Perspectives of Toll-Like Receptors and CD4(+) Helper T Cell Subsets in Acute Viral Encephalitis.Immunological features underlying viral hemorrhagic fevers
P2860
Q21092218-FA8E621D-2DFE-4CED-9394-413D17CAAEBCQ21999123-D654135B-7AB6-43CF-83CE-941462B461D7Q26782367-8D53266D-845A-4328-A8BE-0A896A3C8E1EQ26823627-A74A2AB4-7F9F-4545-ACE9-86D44FA6B447Q26865102-02DB4B23-A2C0-4B30-9C39-86400CE3B6A8Q27300788-B1FA77FC-5B97-4461-8576-14BA3484B5ECQ27320211-5F8C003C-39C2-45F0-AB9F-496957D1ECEBQ27473027-C42D23CF-D771-4351-9A1C-4ECFF57E6639Q27485005-263C1779-4C5B-4947-8750-875609F842B6Q27485041-578573DE-3827-42D4-A855-ECE4FD23823EQ27486116-129A0EB8-BEC1-4BBC-9B30-940784D27474Q27486878-B9F70069-F647-4FAE-82E1-58EB360BC41EQ27487555-700669B1-FCBF-4A7B-BD23-A33CD163B8AEQ27487953-FFFA29E5-7C94-4B67-B80E-9D8F51E7563FQ27489724-D804C73F-F250-420D-81D5-A03C59676DEAQ27489813-67F8ECAF-A147-498C-9219-AE6B48D4A403Q28388716-72AD4266-6358-4EA2-9CFF-3A997F77AF96Q28602577-73CB0ACE-8123-4D6C-A087-9374A95588C9Q28950496-9AE6BC5F-BE9D-4A75-A74F-DD46D333EE80Q29274569-31313FDA-FA46-4E46-8A3E-E0EB754EE9F3Q29616204-607F10FC-9C8B-4756-967F-265876EC189AQ29994529-40C6D7B1-5354-4EC9-921C-706C21E1094CQ29994674-DED80AEB-DA4F-43EA-9CF3-52F3364BEFC1Q30744548-A5B4EDB1-0FC7-43A9-8939-5997D486DC9AQ33914191-A10DC185-58ED-411E-9D22-A88F3D32F1F9Q34109763-C3F4AADF-346F-4C45-AB8A-703A97643D39Q34118209-3DF3A5E8-39BD-4F03-B7CC-9347DED26B89Q34491896-79A932BF-F69C-4484-A1E4-09685F0B347DQ34573913-318B6C1F-1176-4184-B609-06ED30BAEDD3Q34732681-3A427D38-317B-44C7-AE71-182424B3D4E6Q34980404-2A4AA4F3-C14B-4B68-AFA9-AA0707570D24Q35140402-96E3A2F4-78D8-48F9-96ED-ED73FB34693AQ35146556-DC665335-62DB-4CA8-9751-EE6434B5AA12Q35189847-E8B3CF45-87C6-43F5-AADE-2A6019C10A63Q35230291-FBE20422-DBBA-4992-A0E2-DE0C7156BA5FQ35775796-2BD400D0-7403-4228-A8C1-C2286724B424Q35814851-BA90CA52-93BB-4F0A-B677-2EE77A3CBF61Q36031220-986B0A21-CEAC-468A-9DD0-812263763064Q36056898-2741E895-F180-4252-AE34-0A6FF37C2F9EQ36122433-413EFA65-4B61-4FB4-B7FB-914B06A59D38
P2860
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
description
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2005/11/07)
@fr
articolo scientifico (pubblicato il 2005/11/07)
@it
artigo científico (publicado na 2005/11/07)
@pt
artículu científicu espublizáu en 2005
@ast
im November 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 7 November 2005)
@en
vedecký článok (publikovaný 2005/11/07)
@sk
videnskabelig artikel (udgivet 2005/11/07)
@da
name
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@ast
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@en
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@nl
type
label
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@ast
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@en
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@nl
prefLabel
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@ast
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@en
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@nl
P2093
P2860
P3181
P356
P1476
Live attenuated yellow fever 1 ...... nd recombinant T cell epitopes
@en
P2093
Charles M Rice
Matthew L Albert
Randy S Longman
P2860
P304
P3181
P356
10.1084/JEM.20051352
P407
P577
2005-11-07T00:00:00Z